Clinical utility of the 12-gene DCIS score assay: Impact on treatment (Tx) recommendations.

@inproceedings{Alvarado2014ClinicalUO,
  title={Clinical utility of the 12-gene DCIS score assay: Impact on treatment (Tx) recommendations.},
  author={Michael D. Alvarado and Dennis L Carter and J. Michael Guenther and James Hagans and Rachel Y. Lei and Charles E. Leonard and Jennifer Manders and Ap Sing and Michael S Broder and Eunice Y. Chang and Dasha Cherepanov and W. C. Mark Hsiao and Michael Eugene Schultz},
  year={2014}
}
11050 Background: About 20% of breast cancers (BC) are DCIS. Local recurrence (LR) rates with surgery alone are 15-60%; about 50% are invasive. Radiation (XRT) reduces LR by 50% but has not impacte... 

Topics from this paper.

Citations

Publications citing this paper.

Molecular profiling for DCIS.